Comprehensive evaluation of the influence of sex differences on composite disease activity indices for rheumatoid arthritis: results from a nationwide observational cohort study

[1]  A. Boonen,et al.  New indicator for discordance between patient-reported and traditional disease activity outcomes in patients with early Rheumatoid Arthritis. , 2022, Rheumatology.

[2]  R. Westhovens,et al.  Psychosocial Burden Predicts Sustained Remission in Early Rheumatoid Arthritis: Unraveling the Complex Interplay of Well‐Being and Disease Activity , 2021, Arthritis care & research.

[3]  E. Kang,et al.  Sex differences in clinical characteristics and their influence on clinical outcomes in a large observational cohort of patients with rheumatoid arthritis. , 2020, Joint bone spine.

[4]  J. Baker,et al.  Sex Differences in the Achievement of Remission and Low Disease Activity in Rheumatoid Arthritis , 2020, Arthritis care & research.

[5]  M. D. de Wit,et al.  Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal? , 2020, Annals of the rheumatic diseases.

[6]  E. A. Afify,et al.  Sex differences in pain and opioid mediated antinociception: Modulatory role of gonadal hormones. , 2019, Life sciences.

[7]  K. Michaud,et al.  2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures , 2019, Arthritis care & research.

[8]  S. Norton,et al.  Remission vs low disease activity: function, quality of life and structural outcomes in the Early Rheumatoid Arthritis Study and Network , 2019, Rheumatology.

[9]  Shu Yang.  Flexible Imputation of Missing Data, 2nd ed. , 2019, Journal of the American Statistical Association.

[10]  P. Meroni,et al.  Sex and Management of Rheumatoid Arthritis , 2019, Clinical Reviews in Allergy & Immunology.

[11]  C. A. Arce-Salinas,et al.  The effect of concomitant hand osteoarthritis on pain and disease activity in patients with rheumatoid arthritis , 2019, Clinical Rheumatology.

[12]  G. Shaddick,et al.  Gender stratified adjustment of the DAS28-CRP improves inter-score agreement with the DAS28-ESR in rheumatoid arthritis , 2018, Rheumatology.

[13]  Mengtao Li,et al.  Remission rate and predictors of remission in patients with rheumatoid arthritis under treat-to-target strategy in real-world studies: a systematic review and meta-analysis , 2018, Clinical Rheumatology.

[14]  J. Smolen,et al.  Diagnosis and Management of Rheumatoid Arthritis: A Review , 2018, JAMA.

[15]  M. D. de Wit,et al.  Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritis , 2018, Annals of the rheumatic diseases.

[16]  Stef van Buuren,et al.  Flexible Imputation of Missing Data, Second Edition , 2018 .

[17]  M. D. de Wit,et al.  Suppressing Inflammation in Rheumatoid Arthritis: Does Patient Global Assessment Blur the Target? A Practice‐Based Call for a Paradigm Change , 2018, Arthritis care & research.

[18]  K. Michaud,et al.  Impact of Obesity and Adiposity on Inflammatory Markers in Patients With Rheumatoid Arthritis , 2017, Arthritis care & research.

[19]  M. Ward,et al.  Direct and Indirect Determinants of the Patient Global Assessment in Rheumatoid Arthritis: Differences by Level of Disease Activity , 2017, Arthritis care & research.

[20]  W. Dixon,et al.  Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature , 2016, Arthritis Research & Therapy.

[21]  M. Dougados,et al.  Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update , 2015, Annals of the rheumatic diseases.

[22]  M. A. van de Laar,et al.  How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis , 2014, BMC Musculoskeletal Disorders.

[23]  M. A. van de Laar,et al.  Interchangeability of 28-joint disease activity scores using the erythrocyte sedimentation rate or the C-reactive protein as inflammatory marker , 2014, Clinical Rheumatology.

[24]  Y. Saeki,et al.  Current treatments of rheumatoid arthritis: from the ‘NinJa’ registry , 2012, Expert review of clinical immunology.

[25]  Stef van Buuren,et al.  Flexible Imputation of Missing Data , 2012 .

[26]  T. Matsui,et al.  Comparison of composite disease activity indices for rheumatoid arthritis , 2011, Modern rheumatology.

[27]  A. Silman,et al.  UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha, , 2010 .

[28]  A. Silman,et al.  The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report. , 2010, Arthritis and rheumatism.

[29]  A. Silman,et al.  The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Methodological Report Phase I , 2010, Annals of the rheumatic diseases.

[30]  Ahmad M. Nagm,et al.  Gender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA Study. , 2010, Clinical and experimental rheumatology.

[31]  Maurizio Cutolo,et al.  Treating rheumatoid arthritis to target: recommendations of an international task force , 2010, Annals of the rheumatic diseases.

[32]  M. Bredemeier,et al.  Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis. , 2009, Arthritis and rheumatism.

[33]  R. Fillingim,et al.  Sex, gender, and pain: a review of recent clinical and experimental findings. , 2009, The journal of pain : official journal of the American Pain Society.

[34]  A. Taniguchi,et al.  The Influence of Sex on Patients with Rheumatoid Arthritis in a Large Observational Cohort , 2009, The Journal of Rheumatology.

[35]  M. Ahlmén,et al.  Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage , 2009, Annals of the rheumatic diseases.

[36]  B. Bresnihan,et al.  Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA Study , 2009, Arthritis research & therapy.

[37]  L. Carmona,et al.  Are the C-reactive protein values and erythrocyte sedimentation rate equivalent when estimating the 28-joint disease activity score in rheumatoid arthritis? , 2008, Clinical and experimental rheumatology.

[38]  H. Mäkinen,et al.  Sex: a major predictor of remission as measured by 28-joint Disease Activity Score (DAS28) in early rheumatoid arthritis? , 2008, Annals of the rheumatic diseases.

[39]  B. Leeb,et al.  SDAI/CDAI levels in rheumatoid arthritis patients are highly dependent on patient's pain perception and gender , 2008, Scandinavian journal of rheumatology.

[40]  B. Leeb,et al.  Disease activity score-28 values differ considerably depending on patient's pain perception and sex. , 2007, The Journal of rheumatology.

[41]  P. van Riel,et al.  Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis , 2007, Annals of the rheumatic diseases.

[42]  T. Matsui,et al.  Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan , 2007, Annals of the rheumatic diseases.

[43]  M. Ahlmén,et al.  Sex: a major predictor of remission in early rheumatoid arthritis? , 2006, Annals of the rheumatic diseases.

[44]  M. Uffmann,et al.  Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score , 2005, Arthritis research & therapy.

[45]  M. Ahlmén,et al.  The influence of sex on rheumatoid arthritis: a prospective study of onset and outcome after 2 years. , 2004, The Journal of rheumatology.

[46]  P. Tugwell,et al.  A simplified disease activity index for rheumatoid arthritis for use in clinical practice. , 2003, Rheumatology.

[47]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[48]  A. Miller,et al.  Simple rule for calculating normal erythrocyte sedimentation rate. , 1983, British medical journal.

[49]  J. Verhoeff,et al.  A Systematic Review of Devices and Techniques that Objectively Measure Patients' Pain. , 2019, Pain physician.

[50]  R. Latchaw,et al.  Responsible, Safe, and Effective Use of Biologics in the Management of Low Back Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. , 2019, Pain physician.

[51]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[52]  M. Prevoo,et al.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.